Have a feature idea you'd love to see implemented?
Let us know!
PGNY Progyny Inc
Price (delayed)
$15.84
Market cap
$1.43B
P/E Ratio
23.64
Dividend/share
N/A
EPS
$0.67
Enterprise value
$1.35B
Progyny is a leading fertility benefits management company in the US. The company is redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously
Highlights
The stock's price to earnings (P/E) is 65% less than its 5-year quarterly average of 68.0 and 56% less than its last 4 quarters average of 54.8
The net income has grown by 27% YoY and by 2.4% from the previous quarter
PGNY's quick ratio is down by 24% since the previous quarter and by 12% year-on-year
PGNY's equity is down by 20% since the previous quarter and by 2.8% year-on-year
Key stats
What are the main financial stats of PGNY
Market
Valuations
Earnings
Shares outstanding
90.28M
Market cap
$1.43B
Enterprise value
$1.35B
Price to earnings (P/E)
23.64
Price to book (P/B)
3.31
Price to sales (P/S)
1.31
EV/EBIT
16.58
EV/EBITDA
16.05
EV/Sales
1.19
Revenue
$1.13B
EBIT
$81.55M
EBITDA
$84.23M
Free cash flow
$170.92M
Per share
Balance sheet
Liquidity
EPS
$0.67
Free cash flow per share
$1.82
Book value per share
$4.79
Revenue per share
$12.07
TBVPS
$7.26
Total assets
$698.63M
Total liabilities
$242.44M
Debt
$17.06M
Equity
$456.19M
Working capital
$356.87M
Debt to equity
0.04
Current ratio
2.58
Quick ratio
2.47
Net debt/EBITDA
-0.92
Margins
Efficiency
Dividend
EBITDA margin
7.4%
Gross margin
22.1%
Net margin
5.5%
Operating margin
6.3%
Return on assets
8.4%
Return on equity
12%
Return on invested capital
19%
Return on capital employed
17.2%
Return on sales
7.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PGNY stock price
How has the Progyny stock price performed over time
Intraday
-1.8%
1 week
-4.41%
1 month
-7.85%
1 year
-50.09%
YTD
-57.4%
QTD
-5.49%
Financial performance
How have Progyny's revenue and profit performed over time
Revenue
$1.13B
Gross profit
$250.21M
Operating income
$71.2M
Net income
$62.75M
Gross margin
22.1%
Net margin
5.5%
Progyny's operating income has surged by 59% YoY and by 8% QoQ
PGNY's operating margin is up by 34% year-on-year and by 7% since the previous quarter
The net income has grown by 27% YoY and by 2.4% from the previous quarter
Progyny's gross profit has increased by 19% YoY and by 3.1% QoQ
Growth
What is Progyny's growth rate over time
Valuation
What is Progyny stock price valuation
P/E
23.64
P/B
3.31
P/S
1.31
EV/EBIT
16.58
EV/EBITDA
16.05
EV/Sales
1.19
The stock's price to earnings (P/E) is 65% less than its 5-year quarterly average of 68.0 and 56% less than its last 4 quarters average of 54.8
The EPS has grown by 26% year-on-year and by 3.1% since the previous quarter
PGNY's price to book (P/B) is 76% lower than its 5-year quarterly average of 14.0 and 47% lower than its last 4 quarters average of 6.3
PGNY's equity is down by 20% since the previous quarter and by 2.8% year-on-year
PGNY's price to sales (P/S) is 78% lower than its 5-year quarterly average of 6.2 and 55% lower than its last 4 quarters average of 3.0
The revenue is up by 18% year-on-year and by 2.2% since the previous quarter
Efficiency
How efficient is Progyny business performance
The return on sales has grown by 47% year-on-year and by 7% since the previous quarter
PGNY's return on invested capital is up by 17% year-on-year and by 7% since the previous quarter
The company's return on equity rose by 3.4% QoQ
Dividends
What is PGNY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PGNY.
Financial health
How did Progyny financials performed over time
PGNY's total assets is 188% more than its total liabilities
PGNY's quick ratio is down by 24% since the previous quarter and by 12% year-on-year
Progyny's current ratio has decreased by 22% QoQ and by 11% YoY
The company's debt is 96% lower than its equity
PGNY's debt to equity is up by 33% since the previous quarter
PGNY's equity is down by 20% since the previous quarter and by 2.8% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.